SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-012324
Filing Date
2023-10-17
Accepted
2023-10-17 16:37:41
Documents
12
Period of Report
2023-10-11
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk-8k_101123.htm   iXBRL 8-K 28201
  Complete submission text file 0001387131-23-012324.txt   203171

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dmk-20231011.xsd EX-101.SCH 3051
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dmk-20231011_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dmk-20231011_pre.xml EX-101.PRE 22384
6 EXTRACTED XBRL INSTANCE DOCUMENT dmk-8k_101123_htm.xml XML 3296
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 231329996
SIC: 2834 Pharmaceutical Preparations